#Disposable Syringes Market share

[marketwire]

Disposable Syringes Market - Forecast(2024 - 2030)

Disposable Syringes Market Overview:

Disposable Syringes Market size is estimated to reach $24 billion by 2030, growing at a CAGR of 6.7% during the forecast period 2023-2030. The rising demand for injectable medications and increasing adoption of telemedicine are propelling the Disposable Syringes Market growth.

Additionally, the education and training programs for healthcare providers and end-users on the proper use, handling and disposal are creating substantial growth opportunities for the Disposable Syringes Market. As per U.S. Bureau of Labor Statistics, health education specialists and community health workers are expected to grow at a significant rate of 12% by 2031, exceeding the average growth rate for all occupations. This reflects the increasing demand for these professionals and underscores their crucial role in advancing public health and wellness. These factors positively influence the Disposable Syringes industry outlook during the forecast period.

Market Snapshot:  Disposable Syringes Market - Report Coverage:

The “Disposable Syringes Market Report - Forecast (2023-2030)” by IndustryARC, covers an in-depth analysis of the following segments in the Disposable Syringes Market.

Attribute

Segment

By Type

Safety Syringes

Conventional Syringes

Prefilled Syringes

Insulin Syringes

Others

By Syringe Size

Below 5ml

5-10ml

Above 10ml

By Application  

Therapeutic Injections

Immunization Injections

Blood Sample Collection

Others

By End-User

Diagnostics Laboratories

Hospital

Pharmaceutical Industry

Blood Banks

Veterinary

Others

By Geography

North America (U.S., Canada and Mexico)

Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand and Rest of Asia-Pacific)

South America (Brazil, Argentina, Chile, Colombia and Rest of South America)

Rest of the World (Middle East and Africa).

 

COVID-19 / Ukraine Crisis - Impact Analysis:

●        The COVID-19 pandemic has created a heightened demand for disposable syringes due to the urgent need for vaccination campaigns worldwide. Vaccination programs require massive quantities of syringes for administering vaccines, which has resulted in increased production and sales of disposable syringes.

●        The Ukraine crisis has disrupted the supply chain of disposable syringes, including procurement of raw materials, manufacturing and distribution. This can result in challenges in the availability and accessibility of disposable syringes, potentially leading to supply shortages and production delays.

Key Takeaways:

●        Fastest Growth of Rest of the World : Geographically, in the global Disposable Syringes Market share, Rest of the World is analyzed to grow with the highest CAGR of 7.3% during the forecast period 2023-2030. The growth is attributed to the rising healthcare expenditure and infrastructure development in emerging economies. Moreover, the increasing prevalence of chronic diseases and the growing demand for injectable medications are also fueling the market. In November 2021, Revital Healthcare (EPZ) Limited, a Kenyan medical supply manufacturer, announced that it had received nearly $4 million from the Bill & Melinda Gates Foundation to expand the production of auto-disable vaccine syringes. This funding allowed Revital to increase syringe production volume from approximately 72 million.

●        Therapeutic Injections is Leading the Market : According to the Therapeutic Injections Market forecast, the Therapeutic Injections held the largest market valuation of $5.9 billion in 2022 owing to the increasing prevalence of chronic diseases, rising demand for injectable medications and advancements in therapeutic treatments. Therapeutic injections are commonly used for administering medications for conditions such as diabetes, cancer, autoimmune diseases and others.

●        Prefilled Syringes to Register the Fastest Growth : In the Disposable Syringes Market analysis, the Prefilled Syringes segment is estimated to grow with the highest CAGR of 7.2% during the forecast period. The increasing demand for efficient and convenient drug delivery systems drives the adoption of prefilled syringes. These syringes come pre-loaded with a precise dosage of medication, eliminating the need for manual filling and reducing the risk of dosing errors. In May 2022, Terumo Corporation introduced a pre-fillable polymer syringe designed for low-dose applications. This innovative product provides a safe, user-friendly, and efficient treatment solution, catering to the needs of healthcare professionals and patients alike.

●         Adoption of  Injectable Medication : The demand for injectable medications is on the rise due to the increasing prevalence of chronic diseases such as diabetes, cancer, cardiovascular diseases and the growing aging population as well as advancements in therapeutic treatments. Injectable medications are preferred for their fast and effective delivery, precise dosing and ease of administration. In 2022, as per Drug Development & Delivery article, the growth of the injectable drug delivery is projected reach of $83.38 billion by 2030 which demonstrates the rising demand for efficient and convenient administration of medication through injectable routes.

●        Increasing Adoption of Telemedicine : Telemedicine enables patients to consult with healthcare professionals remotely, facilitating remote diagnosis, monitoring and prescription of medications. Disposable syringes play a crucial role in facilitating safe and convenient self-administration of injectable medications for chronic diseases like diabetes and autoimmune disorders. Syringes with their convenience, ease of use and disposable nature have become an essential tool in the telemedicine ecosystem which is driving the demand and growth of the market. In 2022, according to the NCBI report, over 57% of individuals aged 0-17 showed a high inclination towards using telehealth services and indicating a strong willingness among younger individuals to adopt telemedicine.

●        High Cost and Affordability Hamper the Market Growth : Expensive production processes, raw material costs and pricing limit accessibility, especially in resource-constrained settings and pose challenges for patients, healthcare providers and healthcare systems in procuring and using disposable syringes.This factor impedes the Disposable Syringes market growth.

Disposable Syringes Market Share (%) By Region, 2022

Product/Service launches, approvals, patents and events, acquisitions, partnerships and collaborations are key strategies adopted by players in the Disposable Syringes Market. The top 10 companies in this industry are listed below:

Baxter International Inc. (BD® 60 mL Luer syringes)

Medtronic plc (i-Port AdvanceTM)

Fresenius Kabi AG (Amicus® Extracorporeal)

Terumo Corporation (PLAJEX™ COP,  Safe'n'Sound®)

B. Braun SE (Original Perfusor® Syringes, Omnifix® Lock)

Becton, Dickinson and Company. (Ultra-Fine™, Safety-Glide™)

Novo Nordisk A/S (FlexPen®, NovoPen® 5)

Retractable Technologies, Inc. (VanishPoint®, Patient Safe®)

Henke-Sass, Wolf GmbH (HSW HENKE-JECT®– two-part, HSW HENKE-JECT® Insulin)

Nipro Corporation (Dual chamber bags PLW®, Pre-filled syringes [PFS®])

Scope of the Report: 

Report Metric

Details

Base Year Considered

2022

Forecast Period

2023–2030

CAGR

6.7%

Market Size in 2030

$24 billion

Segments Covered

Type, Syringes Size, Application, End-User and Region

Geographies Covered

North America (U.S., Canada and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia, New Zealand and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America), Rest of the World (Middle East and Africa).

Key Market Players

            Baxter International Inc.

            Medtronic plc

            Fresenius Kabi AG

            Terumo Corporation

            B. Braun SE

            Becton, Dickinson and Company.

            Novo Nordisk A/S

            Retractable Technologies, Inc.

            Henke-Sass, Wolf GmbH

            Nipro Corporation

For more Lifesciences and Healthcare Market reports, please click here

[mi-researchreports]

Disposable Syringes Market is poised to grow at a CAGR of 5.8 % by 2027. Factors driving the Disposable Syringes Market are increasing activities by various NGOs , and  rising demand for disposable syringes.

[market-insider]

Pre and Post COVID-19 Impacts on Disposable Syringes Market

The global disposable syringes market size is anticipated to reach USD 22.81 billion by 2030, registering a CAGR of 6.12% over the forecast period, according to a new report by Grand View Research, Inc. The market is expected to expand due to the increasing adoption of safety syringes, technological advancements, increasing demand for vaccines along with growing adoption of self-administration of drugs are supporting the market growth of disposable syringes.

The COVID-19 pandemic has resulted in a significant surge in demand for emergency supplies, medical disposables, medicines, and hospital equipment. As a result of COVID-19, there has been an increase in the production of COVID-19 vaccines, resulted in rise in demand for disposable syringes. In January 2020, in the U.S alone, the Biomedical Advanced Research and Development Authority (BARDA) projected that 650 million to 850 million needles and syringes would be required to administer a vaccination. This in turn, positively impacted the market growth and is estimated to continue to be a growth driver. Moving forward, organizations like United Nations Children's Fund (UNICEF) aimed to purchase 1 billion syringes by the end of 2021 for COVID-19 vaccination operations in COVAX Facility nations. The syringes will all be of the auto-disable (AD) type, as permitted by the World Health Organization, notwithstanding the fact that the vaccines secured by the Facility may vary in their composition and storage needs. As a result, market growth is expected to accelerate in the near future.

Gain deeper insights on the market and receive your free copy with TOC now @: Disposable Syringes Market Report

Companies operating in the market are stepping up their efforts to get their products approved so that manufacturers can start mass production. One of the main areas of concern for manufacturers is the avoidance of unintentional needle stick injuries in healthcare settings. the market players are adopting various strategies, such as mergers & acquisitions, partnerships, product launches and innovations such as introduction of prefilled syringe products to strengthen their foothold in the market. Key players in the market are beefing up their R&D capabilities in order to deploy safe and simple medical practices, which is expected to enhance market growth in the near future. Some prominent players in the disposable syringes market include MEDTRONIC (Covidien); Nipro Corporation; Fresenius Kabi AG; Baxter International, Inc.; B. Braun Melsungen AG; BD.

[industryinsightsandanalysis]

MENA Syringes & Cannula Market: Current Analysis and Forecast (2024-2032)

According to the UnivDatos Market Insights analysis, increasing healthcare expenditure, rising prevalence of chronic diseases, growing geriatric population, government initiatives, expansion of healthcare facilities, advancements in medical procedures, and emerging as a medical tourism destination for advanced healthcare services will drive the scenario of the Syringes & Cannula market. As per their “MENA Syringes & Cannula Market” report, the market was valued at USD 1,505.79 million in 2023, growing at a CAGR of 7.29% during the forecast period from 2024 – 2032.

The healthcare industry in the MENA region is evolving rapidly due to occurrences within the region and the active actions of governments. Critical to this process is the utilization and need for Medical Devices like syringes and cannulas, which are essential in most procedures, from simple injections to complicated surgeries.

Enhanced Healthcare Expenditure and Government Initiatives

Even though most MENA countries are classified as developing, the governments are passionately trying to increase health spending. This increase in the financial share is intended to increase the number of healthcare clinics and ensure that these facilities are well-equipped with relevant products like syringes and cannulas. For instance, Vision 2030 of Saudi Arabia aims to modify the kingdom’s healthcare system, which entails upgrading the technical health infrastructure and providing adequate healthcare facilities.

Similarly, the UAE’s Ministry of Health and Prevention has stepped up efforts to improve the quality of healthcare services. Lastly, the Ministry has set regulations to license high-end products, directly affecting the syringes and cannula market. These initiatives are important as some of them act as guidelines that aim at bringing some level of uniformity in the quality of health services delivered by health practitioners and also in commercialized health services, an aspect that increases the probability of health hazards being minimized due to the safety and efficiency of the medical procedures offered.

Current Trends and Developments in the Market

Recent news includes the following events in the MENA region that are influencing the syringe and cannula market. For instance, a new regulation recently imposed in Egypt requires all syringes to be produced with safety precautions, not allowing reuse, to reduce the rate of infection. This regulation alters the existing situation regarding syringes in Egypt and becomes guidance for other countries as well.

Another new development is that Jordan has recently secured a joint venture with a multinational pharmaceutical company to set up a new industrial equipment factory for medical utensils such as syringes and cannula. Medical and health local economy in Jordan but also an attempt to gradually provide medical products in the Middle East relying on local production.

Access sample report (including graphs, charts, and figures): https://univdatos.com/get-a-free-sample-form-php/?product_id=61467

Regional Collaboration and Innovation:

The countries of the MENA region are slowly realizing the need to engage in regional cooperation in this particular sphere. Among them, the Gulf Cooperation Council (GCC) has led other countries as members to undertake healthcare projects in cooperation. These include common electronic health records and records exchange networks as well as common purchasing contracts for supplies, where aspects such as costs and quality of products like syringes and cannulas are improved.

Technological advancement is also a major factor in the regional market. For instance, researchers in Qatar are in the process of designing biodegradable cannula in a bid to deal with the issue of medical waste and safely dispose of hazardous products for the benefit of patients. This innovation not only serves as a threat to the existing products in the market but also avails the MENA region as a global significant of sustainable healthcare practices.

Difficulties and Future Prospectives:

However, some issues can act as a barrier to the delivery of health care in this region, including political instabilities in some parts and economic imbalances that might affect the uniform distribution of health care supplies. Furthermore, with the ongoing pandemic worldwide, the use of syringes and cannulas in healthcare facilities and other applications has increased, thus exerting more pressure on supply chains.

To deal with these challenges, healthcare infrastructure, strong government policies, regional cooperation, etc., need to be further enhanced. Policymakers should, therefore, shift to influencing the context to produce more positive effects on the innovation systems necessary for developing new health technologies and for training healthcare providers in the use of new medical technologies.

Conclusion:

The demand for syringes and cannulas in the MENA region is poised for significant expansion as the region remains committed to healthcare development and the application of technology. By focusing strategic investment and revising regulations and standards on regional cooperation, the region is not only responding to the emergent healthcare demand of populations today but also building a stronger and better healthcare system for the future. This willingness reflects positivism to increase health as well as illustrates that medical devices such as syringes and cannulas play an imperative part in enhancing such gains.

Contact Us:

UnivDatos Market Insights

Email - contact@univdatos.com

Contact Number - +1 9782263411

Website -www.univdatos.com

[amrutatbrc1]

Intravenous Infusion Pumps Market By Product Type, By Manufacturers, By End-User And Market Trend Analysis Forecast 2033

The intravenous infusion pumps global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Intravenous Infusion Pumps Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size - The intravenous infusion pumps market size has grown strongly in recent years. It will grow from $5.71 billion in 2023 to $6.15 billion in 2024 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to advances in medical technology, aging population, home healthcare services, hospital and healthcare facility expansion, regulatory standards.

The intravenous infusion pumps market size is expected to see strong growth in the next few years. It will grow to $8.51 billion in 2028 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to increasing chronic disease burden, technological innovation, home infusion services, telehealth and remote monitoring. Major trends in the forecast period include smart infusion pumps, wireless and remote monitoring, home infusion therapy, precision medicine and personalized infusion.

Order your report now for swift delivery @ https://www.thebusinessresearchcompany.com/report/intravenous-infusion-pumps-global-market-report

The Business Research Company's reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market's historical performance and projections for future growth.

2. Drivers: Examination of the key factors propelling market growth.

3. Trends: Identification of emerging trends and patterns shaping the market landscape.

4. Key Segments: Breakdown of the market into its primary segments and their respective performance.

5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.

6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Market Drivers - The rise in the prevalence of people with chronic pain, cancer, and diabetes is a significant driver of the demand for intravenous infusion pumps, as these pumps are commonly used to deliver pharmaceutical drugs during the treatment of these diseases. Chronic illnesses and disorders are on the rise around the world, which can be attributed to an aging population and shifts in social behavior that led to a gradual increase of these widespread and expensive long-term medical issues. Infusion pumps are used to transfer regulated doses of nutrients or drugs into a patient's body, such as chemotherapy medicines, pain relievers, antibiotics, insulin, or other hormones. For instance, in March 2022, according to the Australian Bureau of Statistics, an Australia-based autonomous statutory agency tasked with obtaining and analyzing data and making factual recommendations to local, national, and territorial governments, almost fifty percent of the population (46.6%, or 11.6 million) suffered from at least one chronic illness. Therefore, the rise in the prevalence of chronic diseases is expected to drive the growth of the intravenous infusion pumps market.

The intravenous infusion pumps market covered in this report is segmented –

1) By Product: Volumetric, Syringe, Enteral, Ambulatory, IV Disposables, Other Products 2) By Application: Chemotherapy, Diabetes, Gastroenterology, Analgesia/Pain Management, Pediatrics/Neonatology, Hematology, Other Applications 3) By End-User: Hospitals, Ambulatory Surgical Centers, Cancer Treatment Centers, Specialty Clinics, Other End Users

Get an inside scoop of the intravenous infusion pumps market, Request now for Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=3305&type=smp

Regional Insights - North America was the largest region in the intravenous infusion pumps market in 2023. Western Europe was the second-largest region in the intravenous infusion pumps market. The regions covered in the intravenous infusion pumps market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Key Companies - Major companies operating in the intravenous infusion pumps market include B. Braun Melsungen AG, Baxter International Inc., Medtronic plc, Fresenius Kabi AG, Smiths Medical Inc., Becton Dickinson and Company (BD), Terumo Corporation, F. Hoffmann-La Roche Ltd., ICU Medical Inc., IRadimed Corporation, Mindray Medical International Limited, Zyno Medical LLC, Tandem Diabetes Care Inc., Johnson & Johnson, Micrel Medical Devices SA, Boston Scientific Corporation, Pfizer Inc., Q-Core Medical Ltd., Moog Inc., Roche Diagnostics International AG, Nipro Corporation, Animas Corporation, Ypsomed Holding AG, Valeritas Inc., ZOLL Medical Corporation, Codan Medical A/S, Halyard Health Inc., InfuSystem Holdings Inc., Hospira Infusion Systems, CareFusion Corporation

Table of Contents 1. Executive Summary 2. Intravenous Infusion Pumps Market Report Structure 3. Intravenous Infusion Pumps Market Trends And Strategies 4. Intravenous Infusion Pumps Market – Macro Economic Scenario 5. Intravenous Infusion Pumps Market Size And Growth ….. 27. Intravenous Infusion Pumps Market Competitor Landscape And Company Profiles 28. Key Mergers And Acquisitions 29. Future Outlook and Potential Analysis 30. Appendix

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[healthcaremarketanalysis]

Prefilled Syringes Market worth $13.1 billion by 2030 driven by Rising Chronic Illness Rates | MarketsandMarkets™

The global Prefilled Syringes Market is expected to grow from USD 7.1 billion in 2024 to USD 13.1 billion by 2030, at a CAGR of 10.8%. Prefilled syringes are a convenient and precise medical device for delivering single doses of medication, reducing drug waste and extending product lifespan. They are increasingly adopted due to rising chronic illnesses, demand for effective drug delivery, and regulatory support for safer injection methods. Commonly used for biologics, vaccines, and other therapeutic products, these syringes enhance patient safety by minimizing errors and improving dosing accuracy. The market is expanding due to the prevalence of chronic diseases and the growing trend towards self-administration. However, challenges such as product recalls and competition from alternative drug delivery methods may impact growth. The market is driven by rising demand for biologics and biosimilars, with glass and single-chamber syringes expected to dominate. North America leads the market due to its advanced healthcare infrastructure and high demand for precise drug delivery solutions. Key players include BD, Gerresheimer AG, SCHOTT, and West Pharmaceutical Services, among others.

Download PDF Brochure:

Prefilled Syringes Market Dynamics

Drivers

· Rising target disease population

· Rapid growth in generic products

· Rising adoption of self-medication and digitalization

· Affordable cost with increased efficiency of prefilled syringes

· Technological advancements

Restraints

· Dearth of prefilled syringes with integrated safety features

Opportunities

· Growing healthcare infrastructure across emerging markets

· Surge of biologics and biosimilars in biopharma industry

· Increasing adoption of wearable drug delivery technologies

Challenges

· Availability of cheaper alternatives

· Challenges associated with manufacturing of prefilled syringes

Key Market Players

Becton, Dickinson and Company (US), Gerresheimer (Germany), SCHOTT AG (Germany), West Pharmaceutical Services, Inc. (US), Baxter International Inc (US), Ompi (Italy), Catalent, Inc. (US), Weigao Group (China), Vetter Pharma International GmbH (Germany), Nipro Corporation (Japan), Elcam Medical (Israel), YPSOMED (Switzerland), Oval Medical Technologies (UK), SHL Medical AG (Switzerland), Terumo (Japan).

Request Sample Pages

North America accounted for the largest market share of the global prefilled syringes industry, by region in the forecast period. The pre-filled syringe market is anticipated to be dominated by the North American region due to a number of factors, including an advanced healthcare infrastructure, a high prevalence of chronic diseases, and a focus on patient safety and technological innovation. Its dominant position in the market is also a result of the region’s well-established pharmaceutical industry and rising demand for practical and precise drug delivery solutions. Furthermore, continued R&D expenditures and favorable regulatory environments in North America contribute to the expansion and use of pre-filled syringes.

Recent Developments

· In October 2018, Becton, Dickinson and Company launched the BD Intevi 1mL two-step disposable autoinjector.

· In July 2020, Becton, Dickinson and Company entered into an partnership with Biomedical Advanced Research and Development Authority (BARDA) (US)

· In July 2018, Becton, Dickinson and Company acquired Teva Medical Inc. (US)

Content Source:

[researchrealmblog]

How Does Research and Development Boost Medical Injection-Molded Plastics Industry?

The medical injection-molded plastics industry has garnered $23,014.7 million revenue in 2021, and it is projected to rise at a rate of 5.7% from 2021 to 2030, to generate $37,899.5 million in 2030. It is ascribed to the rising consumption of plastic in various healthcare applications, including medical devices, mobility aids, and implant packaging.

Moreover, the surging research & development expenditure, and technological advancements in the healthcare sector propels the requirement for medical-grade injection-molded polymers.

Medical components capture the substantial industry revenue, of approx. 25% and it is further projected to follow the same trend from 2021 to 2030. It is attributed to the massive usage of high-grade plastics for medical equipment manufacturing, including catheters, syringes, containers, and medical bags.

Furthermore, the rising requirement for light and durable medical products, easy to sterilize is projected to propel the industry.

Additionally, the implants generate significant industry revenue, and their sales are projected to rise at a faster rate in the near future. It is ascribed to the rising elderly population, and the growing prevalence of dental implants, orthopedic disorders, endovascular disorders, and cardiovascular diseases.

In addition, the technological advancements in medical implants, led by extensive R&D to provide better results of medical procedures, cause industry propulsion.

Furthermore, mobility aids have experienced the highest CAGR, and it is projected to rise at the fastest rate in the future. It is ascribed to the worldwide rising elderly population, various technological advancements, and increasing healthcare expenses in developing countries.

Moreover, the rising usage of mobility aids, such as drinking aids, wheelchairs, and bath chairs, propels the market expansion.

Injection-molded plastics play a greater role in the transformation of the healthcare sector. These materials are used in the manufacturing of blood sample analysis cuvettes, pregnancy test devices, needle housing, and other medical components. It ensures their lightweight, easy sterilization, and higher affordability.

In addition, these polymers can be utilized in the production of disposable plastic syringes, and blood bags, by molding them. These plastics are used to create antibacterial contact interfaces that can kill bacteria and other pathogens, and reduce infection spread.

Moreover, these plastics can be customized to cater to the requirements of specific applications. They hold the potential to adapt to the smallest and most-delicate molds. Plastics are massively used in the production of surgical equipment, and products, including contemporary pacemakers, stents, catheters, and joint replacement systems.

North America holds the largest industry revenue, of over 40%, and it is projected to follow the same trend in the near future. It is ascribed to growing per capita income, surging healthcare costs, and a rising elderly population.

The U.S. captures a substantial share of the region-based industry, ascribed to highly advanced technology, growing demand for implantable devices, rising health awareness, healthcare policies, and government support.

APAC is projected to experience the fastest growth in the coming future, rising at a rate of over 6%. It is led by the growing application of injection-molded plastics in medical implants, components, and mobility aids.

In addition, the increasing consumer awareness of affordable medical products developed by molded products, rising concern on research and development of medical devices, and growing adoption of cutting-edge technologies in healthcare is projected to propel the industry growth.

Therefore, the medical injection molded plastics industry is projected to rise due to the increasing elderly population.

Source: P&S Intelligence

[msinsights]

Closed System Transfer Devices (CSTD) Market Size, Share, Trends, Business Growth, Top Manufacturers, End Users and Forecast to 2031

The Closed-System Transfer Devices (CSTD) Market, as analyzed by Metastat Insight, has witnessed a remarkable transformation in recent years, driven by the growing emphasis on healthcare worker safety and the need for effective drug handling procedures. These devices have emerged as critical tools, designed to minimize the risk of exposure to hazardous drugs during preparation and administration, offering a vital line of defense for healthcare professionals. 

Get Free Sample Report @ https://www.metastatinsight.com/request-sample/2746

Top Companies

Becton, Dickinson and Company, ICU Medical, Equashield, B Braun Melsungen, Needleless Corporation, Simplivia Healthcare, Corvida Medical, Yukon Medical, CODAN.

These devices offer various features and functionalities, including closed vial access systems, syringe adapters, and transfer bags, all aimed at preventing drug leakage and minimizing exposure risks during drug preparation, administration, and disposal. Additionally, advancements in technology have led to the development of innovative CSTD solutions that enhance ease of use, compatibility with existing equipment, and overall safety.  

The increasing prevalence of cancer and other chronic conditions has fueled the demand for advanced cancer treatments, including chemotherapy. However, the handling of these potent drugs presents significant risks to healthcare workers, making the adoption of closed-system transfer devices an imperative measure. By enclosing the drug transfer process, CSTDs effectively mitigate the potential for accidental exposure, minimizing the adverse health effects associated with prolonged exposure to cytotoxic agents. 

Browse Complete Report @ https://www.metastatinsight.com/report/closed-system-transfer-devices-cstd-market

Additionally, the heightened awareness of occupational hazards within the healthcare sector has played a crucial role in driving the adoption of CSTDs. Regulatory bodies and healthcare organizations worldwide have implemented stringent guidelines and protocols to safeguard the well-being of healthcare professionals. These measures have propelled the adoption of closed-system transfer devices, ensuring compliance with safety standards and mitigating potential liabilities. 

[poonamcmi]

Global Healthcare Consumables Market is Estimated to Witness High Growth Owing to Rising Use of Single-Use Products

Paragraph: The global healthcare consumables market consists of single-use or disposable medical supplies and devices that are used across various sections of the healthcare industry. Some key products in this market include syringes, cannulas, bandages, surgical gloves, drapes, masks and apparels. The growing preference for single-use consumables over reusable products is being driven by concerns of infection control and prevention of cross-contamination. The market provides convenient and hygienic products that can be safely discarded after single use.

The Global Healthcare Consumables Market is estimated to be valued at US$ 172.31 Bn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period from 2024 to 2031.

Key Takeaways

Key players operating in the global healthcare consumables are Procter & Gamble, B. Braun SE, McKesson Medical-Surgical Inc, Medline Industries Inc., Owens and Minor, Smith And Nephew plc, 3M, Baxter, Fresenius Medical Care AG, Cardinal Health, Terumo Medical Corporation, Honeywell Interational Inc., Dynarex Corporation, Kemei, Unigloves, Argentum Medical, Alliqua Biomedical, AccelHeal, Globus Medical. These players are focusing on new product launches and partnerships to strengthen their presence across major markets.

The rising prevalence of chronic diseases and growing geriatric population susceptible to various healthcare conditions offer considerable growth opportunities for players in this Global Healthcare Consumables Market Demand With rising healthcare expenditure globally and improving access to healthcare, demand for consumables is expected to surge significantly over the coming years especially in developing regions.

The market is witnessing increased global expansion with players focusing on emerging countries using strategies like facility expansion, joint ventures and establishing manufacturing plants in such regions to cater to the rising local demand. Regions like Asia Pacific and Latin America offer high growth potential owing to developing healthcare infrastructure and rising medical tourism. Market drivers:

The key driver for the Healthcare Consumables Market Size And Trends  is the ability of single-use consumables to reduce healthcare associated infections and prevent cross-contamination. Other factors like growing healthcare reforms advocating use of disposables, rising surgical procedures, technological advancements and increasing focus on patient safety and hygiene also contribute to the rising demand in this market. With growing med-tech investment and new product development, the market is expected to surge at a steady pace during the forecast period.

PEST Analysis Political: Healthcare consumables market growth is impacted by various regulations related to medical devices and healthcare standards set by the government and healthcare authorities.

Economic: Changes in consumer spending on healthcare and rising disposable incomes impacts demand for healthcare consumables.

Social: Growing geriatric population, increasing prevalence of chronic diseases, and adoption of preventive healthcare drives demand for consumables.

Technological: Advances in medical technology, materials used for manufacturing consumables, and focus on developing eco-friendly products helps grow the market. New technologies also help lower costs and improve quality.

North America region holds the largest market share currently due to developed healthcare infrastructure, availability of reimbursement policies, and presence of key players in the region. The Asia Pacific region is forecasted to grow at the fastest rate over the forecast period due to growing healthcare sector, rising medical tourism, increasing per capita expenditure on healthcare, and growing demand from developing countries like China and India.

The Europe region is also growing at a significant rate supported by improving access to healthcare, government support for research & development, and presence of major established players. The Latin America and Middle East & Africa regions also offer lucrative opportunities for market growth in the coming years. Get More Insights On, Global Healthcare Consumables Market About Author: Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)

[deshpandeisha]

Exploring the Insulin Delivery Market: Innovations and Impact

The global insulin delivery market size reached USD 17.80 billion in 2021 and is expected to register a revenue CAGR of 9.9% during the forecast period, according to the latest analysis by Emergen Research. Increasing number of diabetes patients across the globe, including increase in obese and elderly population, changes in lifestyles, and adequate/established healthcare services are driving market revenue growth. 

Innovations Driving Change:

Smart Insulin Pens: These high-tech pens track doses, offer reminders, and sync data with apps for better management.

Continuous Glucose Monitors (CGMs): While not traditional delivery methods, CGMs are game-changers, providing real-time glucose levels and reducing the need for frequent injections.

Insulin Pumps: These devices automate insulin delivery, mimicking the pancreas's natural function, offering precise control over glucose levels.

Market Dynamics: The market is buzzing with innovation and competition, pushing companies to create more reliable, affordable, and user-friendly solutions. From traditional syringes to cutting-edge wearable tech, options are expanding.

Impact on Diabetes Management: Improved delivery methods mean better adherence to treatment plans, fewer complications, and enhanced quality of life for those managing diabetes.

Challenges Ahead: Despite advancements, challenges like cost, accessibility, and regulatory hurdles persist, limiting universal access to these innovations.

The leading market contenders listed in the report are: Sanofi Diabetes, Nova Nordisk, Omnipod Insulin Management, Eli Lilly and Company, Gerresheimer, Johnson and Johnson, Becton Dickinson, Medtronic PLC, Hoffmann-La Roche Ltd., Braun

The research study examines historic data from 2018 and 2020 to draw forecasts until 2030. The timeline makes the report an invaluable resource for readers, investors, and stakeholders looking for key insights in readily accessible documents with the information presented in the form of tables, charts, and graphs. To Visit Full Report & Table of Contents Insulin Delivery Market: https://www.emergenresearch.com/industry-report/insulin-delivery-market

Market Overview: The report bifurcates the Insulin Delivery market on the basis of different product types, applications, end-user industries, and key regions of the world where the market has already established its presence. The report accurately offers insights into the supply-demand ratio and production and consumption volume of each segment. Segments Covered in this report are:

Diabetes Type Outlook (Revenue, USD Billion; 2019-2030)

Type 1 Diabetes

Type 2 Diabetes

Gestational Diabetes

Prediabetes

Device Type Outlook (Revenue, USD Billion; 2019-2030)

Insulin Syringe

Insulin Pens

Disposable

Reusable

Insulin Jet Injectors

Insulin Pumps

Tethered

Patch

Insulin Needles

Standard Needles

Safety Needles

Insulin Inhalers

External Insulin

Implantable Insulin

Others

Route of Administration Outlook (Revenue, USD Billion; 2019-2030)

Oral/Buccal

Nasal

Subcutaneous Route

Transdermal Route

Others

The research report offers a comprehensive regional analysis of the market with regards to production and consumption patterns, import/export, market size and share in terms of volume and value, supply and demand dynamics, and presence of prominent players in each market. Get An Impressive Discount On This Report@ https://www.emergenresearch.com/request-discount/1432

Regional Analysis Covers: North America (U.S., Canada) Europe (U.K., Italy, Germany, France, Rest of EU) Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC) Latin America (Chile, Brazil, Argentina, Rest of Latin America) Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Key reasons to buy the Global Insulin Delivery Market report:

The latest report comprehensively studies the global Insulin Delivery market size and provides useful inference on numerous aspects of the market, such as the current business trends, market share, product offerings, and product share.

The report offers an insightful analysis of the regional outlook of the market.

It offers a detailed account of the end-use applications of the products & services offered by this industry.

The report holistically covers the latest developments taking place in this industry. Therefore, it lists the most effective business strategies implemented by the market rivals for ideal business expansion.

Request Customization as per your specific requirement@ https://www.emergenresearch.com/request-for-customization/1432

[focusedmarketinsights]

The global syringes and needles market has experienced a surge in demand, driven primarily by factors such as a rising geriatric population, heightened consumer awareness, the prevalence of chronic diseases, and the burgeoning use of syringes and needles for diabetes management. Further propelling the market's growth are technological advancements, the proliferation of new product launches, robust healthcare infrastructure, intensive R&D initiatives, the presence of leading vendors, and supportive governmental policies.

In a more detailed breakdown, as of 2023, syringes command a market share of 66.89%, with predictions indicating an upward trajectory at a CAGR of 8.16%. This growth can be attributed to the escalating demand for disposable syringes fueled by aggressive immunization and vaccination drives. Additionally, adults constitute the largest patient segment, capturing a 69.25% market share in 2023 and projected to achieve 70.16% by 2029. This is largely due to the proliferation of chronic diseases among adults and the spike in diabetic cases.

[tejalbele-2024]

Insulin Syringes Market to Reach $2.40 Bn, Globally, by 2030 at 4.4% CAGR: Allied Market Research

Allied Market Research recently published a report, titled, "Insulin Syringes Market by Syringe Size (3/10 cc Syringe (0.3ml), 1/ 2 cc Syringe (0.5ml), 1cc syringe (1ml), and Others), Disease (Type-1 Diabetes and Type-2 Diabetes), End User (Hospital & Clinics, Homecare Settings, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030". As per the report, the global insulin syringes industry was pegged at USD 1.56 billion in 2020, and is expected to reach USD 2.40 billion by 2030, growing at a CAGR of 4.4% from 2021 to 2030.

𝐅𝐨𝐫 𝐑𝐢𝐠𝐡𝐭 𝐏𝐞𝐫𝐬𝐩𝐞𝐜𝐭𝐢𝐯𝐞 𝐚𝐧𝐝 𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬, 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐚𝐭: https://www.alliedmarketresearch.com/request-sample/3740

𝐌𝐚𝐣𝐨𝐫 𝐝𝐞𝐭𝐞𝐫𝐦𝐢𝐧𝐚𝐧𝐭𝐬 𝐨𝐟 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐠𝐫𝐨𝐰𝐭𝐡

Increase in prevalence of diabetes, surge in the geriatric population, and rise in healthcare expenditure have boosted the growth of the global insulin syringes market. However, high price of insulin and the availability of alternative modes of insulin delivery hinder the market growth. On the contrary, high growth potential in developing countries is expected to open new opportunities for the market players in the future.

𝐂𝐨𝐯𝐢𝐝-𝟏𝟗 𝐬𝐜𝐞𝐧𝐚𝐫𝐢𝐨:

The Covid-19 pandemic led to a lockdown and imposed social distancing measures across several countries. The lockdown disrupted the supply chain, production, and distribution. Patients with high blood pressure and diabetes are at higher risk of getting affected by the virus. Thus, the demand for insulin administration surged during the pandemic. The type-2 diabetes segment to manifest the highest CAGR through 2030

By disease, the type-2 diabetes segment is estimated to portray the highest CAGR of 4.9% during the forecast period. In addition, the segment held the largest share in 2020, accounting for nearly three-fifths of the market, owing to rise in case of type 2 diabetes across the world. The research also analyzes the type-1 diabetes segment.

𝐏𝐫𝐨𝐜𝐮𝐫𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 𝐍𝐨𝐰 : https://www.alliedmarketresearch.com/insulin-syringes-market/purchase-options

𝐓𝐡𝐞 𝐜𝐥𝐢𝐧𝐢𝐜𝐬 𝐬𝐞𝐠𝐦𝐞𝐧𝐭 𝐝𝐨𝐦𝐢𝐧𝐚𝐭𝐞𝐝 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭

By end user, the hospital & clinics segment held the largest share in 2020, contributing to nearly half of the market. In addition, the segment is projected to manifest the highest CAGR of 5.3% during the forecast period, owing to rise in prevalence of chronic diseases such as diabetes and increase in elderly population. The report also analyzes the segments including homecare and others.

𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚 𝐡𝐞𝐥𝐝 𝐭𝐡𝐞 𝐥𝐢𝐨𝐧'𝐬 𝐬𝐡𝐚𝐫𝐞

By region, the market across North America held the largest share in 2020, accounting for nearly two-fifths of the market. This is due to high expenditure on R&D, well-established healthcare infrastructure, and presence of major players & their product availability. However, the market across Asia-Pacific is expected to register the highest CAGR of 6.5% during the forecast period, owing to improvement in R&D facilities, rapidly developing economic conditions, and disposable income.

𝐃𝐨 𝐘𝐨𝐮 𝐇𝐚𝐯𝐞 𝐀𝐧𝐲 𝐐𝐮𝐞𝐫𝐲 𝐎𝐫 𝐒𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐑𝐞𝐪𝐮𝐢𝐫𝐞𝐦𝐞𝐧𝐭? 𝐀𝐬𝐤 𝐭𝐨 𝐎𝐮𝐫 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐄𝐱𝐩𝐞𝐫𝐭: https://www.alliedmarketresearch.com/purchase-enquiry/3740

𝐌𝐚𝐣𝐨𝐫 𝐦𝐚𝐫𝐤𝐞𝐭 𝐩𝐥𝐚𝐲𝐞𝐫𝐬

▪️ Novo Nordisk A/S ▪️ Abbott Laboratories ▪️ Biocon Ltd. ▪️ Cardinal Health Inc. ▪️ Terumo Corporation ▪️ Eli Lilly and Company ▪️ Beckton and Dickinson Company ▪️ Nipro Medical Corporation ▪️ Medline Industries ▪️ Hindustan syringe and medical device Ltd.

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

David Correa 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022 UK: +44-845-528-1300 Hong Kong: +852-301-84916 India (Pune): +91-20-66346060 Fax: +1(855)550-5975 help@alliedmarketresearch.com Web: https://www.alliedmarketresearch.com/reports-store/life-sciences Follow Us on LinkedIn: https://www.linkedin.com/showcase/life-sciences-industry-research/

[blog-site-for-market-research]

Understanding Consumer Preferences in the Dental Industry Market: Research Analysis

Market Overview –

The market for dental products is expected to grow at a compound annual growth rate (CAGR) of 7.1% from 2022 to 2032, or roughly USD 67.1 billion.

The dental industry market encompasses a wide range of products and services related to oral health, including dental equipment, supplies, services, and treatments. With oral health recognized as an integral part of overall well-being, the dental industry plays a crucial role in providing preventive, restorative, and cosmetic dental care to individuals of all ages.

The dental industry market, particularly in dental equipment, is experiencing steady growth. Technological advancements have led to the development of sophisticated dental equipment, enhancing diagnostic accuracy and treatment efficacy. Rising demand for dental services, coupled with increasing disposable income, is driving the adoption of advanced equipment, fueling market expansion.

Market growth is driven by several factors, including increasing awareness of oral health, growing disposable income, and advancements in dental technology and treatments. As people prioritize aesthetics and oral hygiene, there is a growing demand for dental services such as cleanings, whitening, and orthodontic treatments to enhance smiles and maintain oral health.

Technological innovations in the dental industry are shaping the market, offering new treatment modalities, materials, and digital solutions to improve patient outcomes and streamline workflow processes for dental professionals. From digital imaging and CAD/CAM technology to laser dentistry and 3D printing, these advancements enhance diagnostic accuracy, treatment precision, and patient comfort.

Moreover, the aging population and the prevalence of dental conditions such as cavities, gum disease, and tooth loss are driving market growth, as older adults seek comprehensive dental care to maintain oral function and appearance. Additionally, the rising popularity of cosmetic dentistry and dental tourism is expanding the global reach of the dental industry, creating opportunities for growth and innovation.

However, challenges such as access to dental care, affordability, and workforce shortages pose obstacles to market growth. Addressing these challenges requires collaboration between stakeholders, including dental professionals, policymakers, insurers, and technology vendors, to develop sustainable solutions and improve oral health outcomes for populations worldwide

Segmentation –

Discipline, Consumables, and End User are the three segments that make up the global dental industry market.

The global dental industry market has been classified by product into disciplines, consumables, and end users. Due to an increase in root canal therapy, the endodontics segment has the greatest market share in 2019.

Resin composites, dental biomaterial, dental aesthetic, endodontic supplies, gingival retraction material, whitening material, denture adhesive, dental imprint, dental burs, and dental syringe comprise the worldwide dental industry market by consumables. Because resin composites are widely utilized in dental decay treatment, the resin composites segment dominated the consumables segment.

Hospitals & clinics, specialized dental facilities, and dental academic and research institutes make up the worldwide dental industry market by end user. The dentistry industry's expansion is further aided by the availability of trained dental practitioners and improved treatment facilities in hospitals and clinics.

Regional Analysis –

Regional analysis of the dental industry market unveils diverse trends and patterns across different regions worldwide. In North America, the market is characterized by advanced technology adoption, high dental care expenditure, and a strong emphasis on cosmetic dentistry.

The United States, in particular, leads the region with a large market size driven by factors such as a well-established healthcare system and a growing elderly population requiring dental treatments. In Europe, the market is influenced by stringent regulatory standards, leading to a focus on quality and safety in dental products and procedures.

Countries like Germany and the UK are major contributors to the European dental industry, with a robust dental infrastructure and a high level of awareness regarding oral health. In the Asia-Pacific region, increasing disposable incomes, improving healthcare infrastructure, and rising dental tourism drive market growth. Countries like China, Japan, and South Korea are key players in this region, witnessing a surge in demand for both preventive and cosmetic dental services.

Latin America showcases a growing demand for dental care, spurred by rising disposable incomes and increasing awareness of oral hygiene. The Middle East and Africa witness expanding dental markets, driven by improving healthcare facilities and rising dental health awareness campaigns. Understanding these regional dynamics is crucial for stakeholders in the dental industry to tailor their strategies and offerings according to the unique needs and preferences of each market, ensuring sustained growth and success.

Key Players –

Dental Industry prominent players are Abano Healthcare Group Limited, 3M, Allergan plc, Coltene Group, Dentsply Sirona, Coast Dental, Dental Service Group, Axis Dental, and Henry Schein, Inc., among others

Related Reports –

Urinalysis Test

Celiac Disease Treatment

Healthcare Enterprise Software

Amniotic Membrane

For more information visit at MarketResearchFuture

[market-insider]

Single-Use Bioprocessing Market in the Quest for Efficient Biopharmaceutical Production

The global single-use bioprocessing market size is projected to reach USD 80.13 million by 2030, registering a compound annual growth rate (CAGR) of 16.24% over the forecast period, according to a new report by Grand View Research, Inc. The demand for single-use bioprocessing offerings is driven by the commercial advantages offered, including a reduction in costs and time required for bioprocessing operations. Originally used for monoclonal antibody production, single-use technologies are also gaining traction for cell and gene therapy manufacturing. As a result, broadening the scope of applications in biomanufacturing operations is likely to drive industry growth.

Single-use Bioprocessing Market Report Highlights

The simple & peripheral elements segment held the largest share in 2023 due to the significant adoption of these products as a result of a variety of customizable options available for bioprocessing applications

The upstream bioprocessing workflow segment accounted for the largest share in 2023. Continuous developments and betterment in technologies for upstream bioprocessing are driving the segment growth

North America was the leading region in 2023 due to the high R&D spending and growth of the biopharmaceutical manufacturing sector in the region

Furthermore, the presence of key players, such as Thermo Fisher Scientific, Inc. and Danaher Corp., is driving the regional market

The biopharmaceutical manufacturers end-use segment dominated the industry in 2023 and accounted for the maximum revenue share. This was due to the high demand for biologics and heavy investments in cell & gene therapy manufacturing

For More Details or Sample Copy please visit link @: Single-use Bioprocessing Market Report

Furthermore, strategic initiatives from key players are expanding the industry's growth prospects. For instance, in July 2021, Cytiva and Pall Corp. announced investment plans for capacity expansion over two years. Among other key products, more than USD 300 million were invested in single-use technologies, such as bioreactor bags for cell expansion, used to make personalized therapies and syringe filters for scientific research. Similarly, the growing adoption of single-use equipment for in-house and contract manufacturing has opened new avenues for the flow of investments in this space. The industry is witnessing significant advancements in several product portfolios, including disposable probes and sensors, stirring systems, bioreactor designs, and filtration technologies, which are expected to contribute to strong revenue growth.

The benefits offered by single-use bioprocessing systems have enabled biopharmaceutical manufacturers to offer their products faster to the market by introducing multi-product facilities, entering into partnerships, or outsourcing pipeline products for contract development and manufacturing. For instance, in January 2021, Sartorius AG partnered with RoosterBio, a leading supplier of human Mesenchymal Stem/Stromal Cells (hMSC). This collaboration aimed at advancing cell & gene therapy manufacturing by leveraging the single-use manufacturing technologies from Sartorius AG. The COVID-19 pandemic has generated new growth opportunities for key stakeholders in the industry.

[chemicalresearchupdates]

Sulfone Polymer Market: Innovations and Advancements in Electronic Components

Sulfone polymer, also known as polysulfone, is a highly temperature resistant material used for its strength, durability and resistance to chemicals. It is commonly used to produce medical devices such as dialyzers, blood filters and artificial organs owing to its bio-compatibility. Sulfone polymers do not leach any toxic chemicals and can withstand high temperatures, making them ideal for uses in the medical industry.

The global sulfone polymer market is estimated to be valued at US$ 2.65 Bn in 2023 and is expected to exhibit a CAGR of 9.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity: Increasing Demand from Medical Industry The key market opportunity for sulfone polymer market lies in the increasing demand from the medical industry. Sulfone polymers are widely used in medical devices such as dialyzers, syringes, blood oxygenators, contact lenses and surgical instruments owing to their bio-compatibility and chemical resistance. Growing elderly population and increasing healthcare expenditure is expected to boost the demand for various medical devices. As sulfone polymers are an integral part of manufacturing these devices, increasing demand from the medical industry will have a positive impact on the growth of the sulfone polymer market over the forecast period. Advantages of sulfone polymers such as non-toxicity, chemical resistance and heat stability make them suitable for critical medical applications. Porter’s Analysis

Threat of new entrants: The threat of new entrants in the sulfone polymer market is moderate. High capital requirements and established brand value of existing players creates barriers for new players.

Bargaining power of buyers: The bargaining power of buyers is high due to availability of substitutes. Buyers can negotiate on price and demand customized products.

Bargaining power of suppliers: The bargaining power of suppliers is moderate. Suppliers of raw materials like bisphenol-A and PBT have moderate switching costs.

Threat of new substitutes: The threat of substitutes is high due to availability of alternative polymers like polyetherketone, polyetherimide and polyphenylene sulfide in the market.

Competitive rivalry: The competitive rivalry is high among the key players to gain major market share. SWOT Analysis

Strength: High heat and chemical resistance properties make sulfone polymers suitable for use in automotive, electronics and healthcare industries. Excellent dimensional stability and low moisture absorption characteristics provides durability.

Weakness: High production cost of sulfone polymers compared to alternatives limits its use in price sensitive applications. Complex production process poses challenge for mass production.

Opportunity: Growing demand for lightweight and durable polymers from automotive and aerospace industries due to stringent regulations creates market opportunity. Increasing R&D on polymer blends can help utilize properties efficiently.

Threats: Volatility in price of crude oil poses threat to raw material supply and price fluctuations. Stringent environmental regulations regarding production waste disposal can increase compliance cost. Key Takeaways

The global sulfone polymer market is expected to witness high growth during the forecast period of 2023-2030. The market is expected to reach a value of US$ 4.45 Bn by 2030 expanding at a CAGR of 9.3% from 2023 to 2030.

The Asia Pacific region dominates the global sulfone polymer market with over 35% share in 2023 in terms of value. China leads the Asia Pacific sulfone polymer market due to presence of large automotive and electronics industry. Key players operating in the sulfone polymer market are Solvay, BASF, Sumitomo, Evonik, Sabic, Ensinger GmbH, PolyOne Corporation, RTP Company, Mitsubishi Chemical, and Omnia Plastica SPA. Solvay and BASF capture over 35% of the global sulfone polymer market share. Solvay offers a wide range of sulfone polymers under the name Udel P-1700, Udel P-1750, Udel P-1800 for automotive, medical and electronics applications.

[infinitiresearch]

Prefilled Syringes Market| Analysis, Growth and Forecast, 2023 – 2027

Originally published on Technavio: Prefilled Syringes Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, Germany, UK, China - Size and Forecast 2023-2027

The Prefilled Syringes Market is undergoing substantial analysis, focusing on the regions of North America, Europe, Asia, and the Rest of the World (ROW), including key countries like the US, Canada, Germany, the UK, and China. The market analysis for the forecast period of 2023-2027 provides comprehensive insights into the factors influencing the growth and dynamics of the prefilled syringes sector.

**North America** emerges as a prominent market for prefilled syringes, with the US and Canada at the forefront of adoption. The region's market growth is attributed to factors such as an aging population, increasing prevalence of chronic diseases, and a robust healthcare infrastructure. Additionally, the emphasis on patient safety and the convenience offered by prefilled syringes contribute to their widespread use in this region.

**Europe** is a significant player in the prefilled syringes market, with Germany and the UK driving adoption. The region benefits from a well-established healthcare system and a growing awareness among healthcare professionals and patients about the advantages of prefilled syringes. Stringent regulations focusing on the safety and efficacy of drug delivery systems further fuel the market growth in Europe.

The **Asian market**, particularly in countries like China, is experiencing a surge in demand for prefilled syringes. Factors such as a rising geriatric population, increasing healthcare expenditures, and a growing focus on vaccination programs contribute to the expanding market share in Asia. The adoption of innovative drug delivery technologies and a shift towards self-administration of drugs also drive the market dynamics in this region.

The **Rest of the World (ROW)**, comprising various emerging markets, demonstrates a growing interest in prefilled syringes. Factors such as improving healthcare infrastructure, rising disposable income, and increasing awareness about advanced drug delivery methods contribute to the market growth in these regions.

To Learn deeper into this report , View Sample PDF

The forecast for the prefilled syringes market indicates a positive trajectory, driven by factors like technological advancements, the need for convenient drug delivery systems, and a rising preference for self-administration of medications. As the healthcare landscape continues to evolve, prefilled syringes are expected to play a pivotal role in ensuring safe and effective drug administration globally.

For more information please contact.